Elan sees sales of prized Tysabri drug rise sharply

DUBLIN (Reuters) - Elan said sales of the multiple sclerosis drug Royalty Pharma wants to get its hands on through its bid for the Irish drugmaker rose by 14 percent year-on-year to $456 million in the first quarter.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/04/elan-sees-sales-of-prized-tysabri-drug_24.html